Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. - Wikidata - awgldk - TriplyDB

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

http://www.wikidata.org/entity/Q37179338

about

The Preclinical Research Progress of Stem Cells Therapy in Parkinson's Disease A Compendium of Preparation and Application of Stem Cells in Parkinson's Disease: Current Status and Future Prospects The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats Cell-based screening: extracting meaning from complex data.Physiological characterisation of human iPS-derived dopaminergic neurons Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine.Efficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform.Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.Transplantation of induced pluripotent stem cells improves functional recovery in Huntington's disease rat model.Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons Rat hair follicle stem cells differentiate and promote recovery following spinal cord injury Moving stem cells to the clinic: potential and limitations for brain repair Potential for cell therapy in Parkinson's disease using genetically programmed human embryonic stem cell-derived neural progenitor cells.Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.Oxidative stress, redox regulation and diseases of cellular differentiation.Successful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.Development of stem cell-based therapy for Parkinson's disease.Treating non-motor symptoms of Parkinson's disease with transplantation of stem cells Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1 Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson's disease model.Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells.Neonatal immune-tolerance in mice does not prevent xenograft rejection.Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation Replacing Dopamine Neurons in Parkinson's Disease: How did it happen?Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives Advances in stem-cell--generated transplantation therapy for Parkinson's disease.Adult subventricular zone neural stem cells as a potential source of dopaminergic replacement neurons The potential of alternate sources of cells for neural grafting in Parkinson's and Huntington's disease.Stem cell reprogramming: basic implications and future perspective for movement disorders.Canonical and noncanonical Wnt signaling in neural stem/progenitor cells.Clinical translation of stem cell transplantation in Parkinson's disease.Treatment of Parkinson's disease using cell transplantation.Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.Gold nanoparticles enhance the differentiation of embryonic stem cells into dopaminergic neurons via mTOR/p70S6K pathway.Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.Brain repair and reprogramming: the route to clinical translation.

P2860

Q26744445-6A6609AB-2938-48B9-B870-D0E5C3DD9555 Q26746033-F76543FE-5693-41BC-8CFF-62AD76E761B2 Q26765876-3AA9E675-6D9B-473C-A18C-F0882A53874E Q26772879-1D9F9713-BF59-4B10-A611-FC3E50D68C05 Q27301260-4C8CDA8A-3555-4478-91D6-71EB04078E3B Q27305816-CE2FBDA3-CEBE-47F5-ADB8-28554E1B6291 Q27324718-64027C5D-C40F-4205-AF95-C90E0A02E664 Q30638240-28D11CBC-5DF7-49B1-B046-A7BBEDB6F4E7 Q30835073-AB02B791-6330-4335-94F8-7EA5BB27EFC6 Q33722351-A2FD92FD-6A59-4E68-A206-521355E1EC81 Q33939904-238BD1E2-7322-4BB8-9638-00C6AC97A525 Q33975612-65890644-E003-4A51-BFF4-60A813A8EB5D Q34095001-9BAC7823-A55F-4E0A-A9C0-16EEA9F1D5E6 Q34470920-63B43ACC-660C-4C6E-A8C0-C5D1E75F3457 Q35299587-E585346D-5DA8-4475-8180-EFFEF7E9A7EF Q35484942-24A374F1-76D4-47F8-BB35-DE55AC2DF650 Q35611511-E035575D-EAEE-47AC-BD94-5884B4DF5E9A Q35711351-E970CA5C-6B11-40E7-A601-E4375FF9550D Q36025246-7E251271-CA84-4FDD-831D-865A4C0BFD53 Q36790753-54F240B8-77FB-474E-A7BC-9BB855A77BDD Q36805014-E69B57D2-0938-4FCF-A8FE-E4DB09C123BE Q36882491-1B7401AA-A961-4407-A5F2-1CDA652A7343 Q37200879-F8C0A378-6C28-4419-9029-E806481CC2E6 Q37638358-16A05FFE-2655-4A15-8E5F-9F381662EF18 Q37660450-91F0A6DB-E69C-4CD4-B4E4-9C43F42613BC Q37693379-3089F21A-2167-4AB4-8790-5D51B6616CE4 Q37707825-79DC27E8-4A02-45D3-BD7C-5239E69D1283 Q38179448-16EB5F5C-4900-477A-9D67-19B34A2B6E8B Q38191589-810CA8FF-3F27-4843-BAF9-BB3EF8212741 Q38260092-C8CDA5F1-431A-46BE-848F-7D7C2F367479 Q38302834-AC8C0D7C-A7FC-48D3-B3BD-DA27F5879AC8 Q38573790-7F4B05F0-8A9D-4016-AFDC-CC41CEFCDD3E Q38579206-654C28E8-43BA-4BF4-8B2A-DBF6B3529B0F Q38594913-EBFB196E-407F-4166-A5DA-EADCA97C823C Q38599709-CFF79EEF-73E6-471B-A758-911B662E42D7 Q38682364-CD834F33-4088-43F8-B878-48F01B944392 Q38691269-30ABF33F-8820-45BA-AE67-AFDF0C2577F7 Q38693456-0AB1FD4A-32E1-44CD-A082-A925A92ECA86 Q38752574-94C1A72E-B532-4B8E-80B6-BF2FEBB14FEC Q38829948-A5DB525D-D9D2-4B70-85CB-DBAD189665F3

P2860

Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.

http://www.wikidata.org/entity/Q37179338

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@en

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@nl

type

label

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@en

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@nl

prefLabel

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@en

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@nl

P1433

Q37179338-83604F26-CDFC-4773-823D-B6DD2853F998

P1476

Q37179338-FF0337DA-00BF-4A51-8AC3-A56D4F6AD8FD

P2093

Q37179338-059F9A65-53E9-4CC2-8A3A-47722811E75A

Q37179338-16FFF58B-6B2F-4CFA-928D-5DF81C8F3CA2

Q37179338-295233EF-3C87-4684-B015-B276719E7032

Q37179338-2B31E13C-53E8-4C09-A4D4-64A48D0344E9

Q37179338-2F3944CC-3C1D-43FA-BD6F-E5C862CD4082

Q37179338-5271429E-C7F7-4CCC-AED7-6C4C5A031B11

Q37179338-5F2478D3-ABDC-4B2A-930C-F5F9BEDA6EF0

Q37179338-82520C86-6522-4ECF-9035-9DB81CDEAD5B

Q37179338-8D9692A3-C8E7-441B-9DE5-467A3C688D01

Q37179338-BB33921F-AC56-4135-BE5C-8997EAB24351

P2860

Q37179338-12C38E5A-DEAC-42D4-954E-19C35B26230D

Q37179338-19DAF89A-DADA-4CBF-84A5-7DB2F7994752

Q37179338-26D6192A-2958-4A56-A821-5086DABE0A51

Q37179338-2768D00E-E89B-45D9-B32E-C8C12988685B

Q37179338-28336727-C65F-462D-B27E-42D2BF432897

Q37179338-295888D5-3403-4D66-B62D-829E80254559

Q37179338-2C45A525-2D3F-405A-9615-C48F9316477D

Q37179338-3721F0AB-51CF-44CA-AC0A-13689EC4BB1B

Q37179338-385FFB7D-2260-4BE3-B5F6-21698158536A

Q37179338-394FFF0B-E24C-4C38-A7C1-21D75370C610

P304

Q37179338-B57876F9-DDEB-4CAB-84CE-E2673BF57466

P31

Q37179338-AFDA42FB-D981-4FF4-B653-26CDBF7D4CDC

P356

Q37179338-3B877FCB-291F-4DA9-9720-6BC4D68981F7

P433

Q37179338-A31405DC-F041-4371-9296-DE4281FD056E

P478

Q37179338-6605094B-C06E-4161-887E-BC6179F22082

P577

Q37179338-80873724-37D3-40D2-8446-2578FA02E046

P5875

Q37179338-9D68B52B-2D26-4732-BC0F-4631C034882E

P698

Q37179338-8657F684-B4E7-4640-949F-F4750692357B

P921

Q37179338-31D57003-201B-4473-A207-B1780334DD72

Q37179338-733BCEE9-A204-468B-8E49-2D8B1B032249

P932

Q37179338-99775A0E-E8EA-47E2-BA19-06F7452A085D

P356

P1433

P1476

Improved cell therapy protocol ...... -derived dopaminergic neurons.

@en

P2093

Arnar Astradsson

http://www.w3.org/2001/XMLSchema#string

Gaynor Smith

http://www.w3.org/2001/XMLSchema#string

Helle Bogetofte

http://www.w3.org/2001/XMLSchema#string

Johan Jansson

http://www.w3.org/2001/XMLSchema#string

Maria Sundberg

http://www.w3.org/2001/XMLSchema#string

Michele Moore

http://www.w3.org/2001/XMLSchema#string

Ole Isacson

http://www.w3.org/2001/XMLSchema#string

Oliver Cooper

http://www.w3.org/2001/XMLSchema#string

Penelope Hallett

http://www.w3.org/2001/XMLSchema#string

Roger Spealman

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease.

CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells

The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A

Generation of germline-competent induced pluripotent stem cells

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate

A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo

Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells

P304

1548-1562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/STEM.1415

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236692423

http://www.w3.org/2001/XMLSchema#string

P698

23666606

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

3775937

http://www.w3.org/2001/XMLSchema#string